×

img Acces sibility Controls

Research Projects Banner

Research Projects

Mechanistic understanding of functional role of human TRIM28 and ELL in eukaryotic transcriptional regulation involving NELF complex

Implementing Organization

CSIR-Indian Institute Of Chemical Biology (CSIR–IICB), West Bengal
Principal Investigator
Dr. Debabrata Biswas
CSIR-Indian Institute Of Chemical Biology (CSIR–IICB), West Bengal

About

Aberrant gene expression through transcription defects is a common cause of human disease, including developmental defects and cancers. The pause and release step at the promoter proximal region is crucial for the expression of developmentally-regulated genes. RNA polymerase II (Pol II) is released from the promoter and paused by DSIF and NELF protein complexes. Phosphorylation of these complexes and conserved heptad repeats of Pol II leads to the dissociation of the NELF complex, promoting transcription elongation. No other mechanisms have been widely accepted in eukaryotic transcriptional regulation. This project aims to propose a novel mechanism involving the E3 ubiquitin ligase function of TRIM28, targeting NELF-E and NELF-A components of the NELF complex. This leads to the degradation of the entire NELF complex at the promoter proximal region, allowing paused Pol II to enter the productive elongation step. The transcription elongation factor ELL is hypothesized to enhance this step by increasing overall ubiquitination by TRIM28. This study has the potential to unravel a novel mechanism of transcriptional regulation, influencing the understanding of various human disease pathogenesis.
Funding Organization
Funding Organization
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Molecular Biology, Biochemistry
Start Year
2023
End Year
2026
Sanction Amount
₹ 61.77 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop